Hyaluron, PPD, Parexel, MDS Pharma Services, Kendle and ClinPhone - People on the move

By Emilie Reymond

- Last updated on GMT

Related tags Vice president Clinical trial Vice president of the united states

Hyaluron, PPD, Parexel, MDS Pharma Services, Kendle and ClinPhone
have all had people on the move in the world of pharmaceutical
outsourcing in May.

Hyaluron Contract Manufacturing​ (HCM), which specialises in aseptic formulation and filling of liquid parenteral drugs, has created a new position of vice president of quality and has chosen Robert Haggerty​ to fulfil the role. Under his new position, Haggerty will be responsible for overseeing quality and regulatory compliance at the company's Burlington, Massachusetts facility. Most recently, Haggerty was the director of quality assurance at Alexion Pharmaceuticals where he was in charge of quality assurance start-up activities at its new biotech facility. Previously, he held positions at Ben Venue, Dupont Merck, and Transkaryotic Therapies (now Shire). PPD​ has also made a new appointment this month. William Sharbaugh​ was named chief operating officer. Sharbaugh was previously vice president of global development operations at Bristol-Myers Squibb, where he was responsible for strategic direction for clinical operations in 55 countries. Prior to BMS, he spent 10 years at Merck & Co in different jobs in clinical supply operations, sales and manufacturing. "Bill Sharbaugh brings extensive leadership experience and skills as well as a vision that complements and aligns well with the strategic direction we have charted for PPD,"​ said Fred Eshelman, chief executive officer of PPD. Meanwhile, contract research organization (CRO) Parexel​ has named Joe Avellone​ corporate vice president of clinical research operations in North and Latin America. Avellone will lead operational aspects of the company's Phase II-IV clinical development programmes for clients, including project management, clinical operations, and management of the Americas Medical Affairs group, Parexel said. Prior to joining the firm, Avellone was the former chief executive officer of Veritas Medicine, a healthcare technology company supporting clinical research trials. Another big player in the CRO arena has announced new HR changes in the past month. Pennsylvania-based MDS Pharma Services​ has appointed James Pusey​ as vice president and general manager of the company's global clinical development business, which manages late-stage clinical drug trials. Pusey was previously CEO of biotech company OrthoLogic and prior to that role, he was executive vice-president for Neurology at Serono, where he was responsible for late-stage drug development, including co-development projects with Pfizer. In addition, he has held the positions of vice-president of marketing and therapeutic area leader for central nervous system, pain and infection at AstraZeneca in the US. Still in the clinical outsourcing space, Kendle​ has promoted Patricia Steigerwald​ to vice president of the company's global late phase business. In her new role, Steigerwald's objective will be to drive continued growth of the Late Phase brand globally, with a focus on Phase IIIb and IV trials, health economics and outcomes research. She has more than 20 years of CRO and clinical experience and was most recently senior director of the segment. "Phase IIIb/IV continues to be an area of significant customer need, with the global outsourcing market estimated to reach $4.7 to $4.8 billion by 2010,"​ said Kendle CEO Dr Candace Kendle. "Pat's expertise in the strategic and operational design and execution of large clinical endpoint trials will further position Kendle to capitalise on this exciting and growing marketing opportunity in the global late phase market." ​ And last but not least, UK eClinical firm ClinPhone​ has recently appointed Michael Smyth​ as vice president of product management in its trial management solutions group. The trial management solutions group includes ClinPhone's CTMS, site manager and e-learning products. Smyth will work from ClinPhone's New Jersey office in the US where he will work with the development and sales team to add functionality to the products, manage client relationships and understand market needs. He will also be responsible for increasing the overall presence of the company's trial management solutions within the global market. ​Before working for ClinPhone, Smyth held a number of senior positions at several organisations, including business development director at Premier Research and most recently, head of global strategic accounts with VivoMetrics.

Related topics Clinical Development Phase III-IV

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

Related suppliers

Follow us


View more